PepGenPEPG
PEPG
About: PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
Employees: 79
0
Funds holding %
of 7,299 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
109% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 11
18% more funds holding
Funds holding: 61 [Q4 2024] → 72 (+11) [Q1 2025]
0.76% more ownership
Funds ownership: 76.68% [Q4 2024] → 77.45% (+0.76%) [Q1 2025]
6% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 18
62% less capital invested
Capital invested by funds: $94.7M [Q4 2024] → $35.6M (-$59.2M) [Q1 2025]
70% less call options, than puts
Call options by funds: $35K | Put options by funds: $115K
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$8
437%
upside
Avg. target
$8
437%
upside
High target
$8
437%
upside
1 analyst rating
1 positive
100%
0 neutral
0%
0 negative
0%
HC Wainwright & Co. Andrew Fein | 437%upside $8 | Buy Maintained | 29 May 2025 |
Financial journalist opinion
Based on 75 articles about PEPG published over the past 30 days
Neutral
Accesswire
3 hours ago
PEPG Class Action Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of The Lead Plaintiff Deadline in The PepGen Inc. Class Action Lawsuit
SAN DIEGO, CA / ACCESS Newswire / June 16, 2025 / Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired PepGen Inc. (NASDAQ:PEPG) securities between March 7, 2024 and March 3, 2025. PepGen is a clinical-stage biotechnology company that focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases.
Neutral
Accesswire
3 hours ago
Join Class Action to Recover Losses from PepGen Inc. (PEPG) - Contact Levi & Korsinsky Before August 8, 2025
NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your PepGen Inc. (NASDAQ:PEPG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pepgen-inc-lawsuit-submission-form?prid=153355&wire=1&utm_campaign=31 or contact Joseph E. Levi, Esq.
Neutral
Accesswire
6 hours ago
Join Class Action to Recover Losses from PepGen Inc. (PEPG) - Contact Levi & Korsinsky Before August 8, 2025
NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your PepGen Inc. (NASDAQ:PEPG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pepgen-inc-lawsuit-submission-form?prid=153352&wire=1&utm_campaign=31 or contact Joseph E. Levi, Esq.
Neutral
Accesswire
6 hours ago
ROSEN, LEADING INVESTOR COUNSEL, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PEPG
NEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / WHY: New York, N.Y., June 16, 2025.
Neutral
GlobeNewsWire
7 hours ago
PEPG LAWSUIT ALERT: Levi & Korsinsky Notifies PepGen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in PepGen Inc. ("PepGen Inc." or the "Company") (NASDAQ: PEPG) of a class action securities lawsuit.
Neutral
Accesswire
7 hours ago
Contact Levi & Korsinsky by August 8, 2025 to Join Class Action Against PepGen Inc. (PEPG)
NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your PepGen Inc. (NASDAQ:PEPG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pepgen-inc-lawsuit-submission-form?prid=153330&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq.
Neutral
Accesswire
8 hours ago
Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers - PEPG
NEW YORK, NY / ACCESS Newswire / June 16, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against PepGen Inc. ("PepGen" or the "Company") (NASDAQ:PEPG) and certain officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 25-cv-xxxxx, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired PepGen securities between March 7, 2024 and March 3, 2025, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
Neutral
Accesswire
9 hours ago
Investors Urged to Contact Levi & Korsinsky for Information Before August 8, 2025 - PepGen Inc. (PEPG)
NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your PepGen Inc. (NASDAQ:PEPG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pepgen-inc-lawsuit-submission-form?prid=153307&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq.
Neutral
GlobeNewsWire
9 hours ago
Shareholders who lost money on PepGen Inc. (NASDAQ: PEPG) Should Contact Wolf Haldenstein
NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed on behalf of all investors who purchased or otherwise acquired securities of PepGen Inc. (NASDAQ: PEPG) between March 7, 2024 and March 3, 2025, inclusive (the “Class Period”).
Neutral
PRNewsWire
9 hours ago
PEPG Investors Have Opportunity to Lead PepGen Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES , June 16, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against PepGen Inc. ("PepGen" or "the Company") (NASDAQ: PEPG) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between March 7, 2024 through March 3, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before August 8, 2025.
Charts implemented using Lightweight Charts™